Oxford-AstraZeneca vaccine 95% effective in controlling ’Delta’ variants: NRC Chairman

The Oxford-AstraZeneca COVISHIELD vaccine was 95% effective in controlling the ’Delta’ variants which have been identified in the country, the National Research Council (NRC) Chairman Prof. Hemantha Dodampahala said.